methoxamine has been researched along with almokalant in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Abrahamsson, C; Andersson, B; Carlsson, L; Duker, G; Schiller-Linhardt, G | 1 |
| Carlsson, L; Hallman, K | 1 |
3 other study(ies) available for methoxamine and almokalant
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cats; Drug Administration Schedule; Electrophysiology; Heart; Infusions, Intravenous; Long QT Syndrome; Male; Methoxamine; Propanolamines; Purkinje Fibers; Rabbits; Torsades de Pointes | 1993 |
Prevention of class III-induced proarrhythmias by flecainide in an animal model of the acquired long QT syndrome.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiology; Flecainide; Male; Methoxamine; Propanolamines; Rabbits; Torsades de Pointes | 1995 |